The emerging treatment of the medication represents a exciting development in the care of type 2 diabetes. Different to existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide922119.slypage.com/42578139/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment